DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...

GST applicants from Kerala, Nagaland, and Telangana must follow new Aadhaar-based biometric authentication and document ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

Chris Martin, Chairman and Non Executive Director of Myricx Bio said, “I am delighted to welcome Paolo to the board. He brings extensive leadership experience in R&D and commercialisation in the ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...

While Pfizer tackles weaker revenue for Covid-19 vaccines and drugs, along with an underwhelming launch of its respiratory ...

Federal scientists are closely studying H5N1 genetic sequences from California dairy workers in search of any dangerous ...

Discover why Gilead Sciences is a strong buy with potential blockbuster drugs in HIV and oncology, favorable valuation, and a ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...